Anixa Biosciences Inc (ANIX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $91.08M
Last updated: Nov 17, 2026 at 11:04 AM ET
Anixa Biosciences Inc (ANIX) Stock Forecast
Analysts expect Anixa Biosciences (ANIX) to earn -$0.31 per share in the fiscal year ending Oct 31, 2027. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the quarter ending Jan 31, 2027, the EPS consensus is -$0.08.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 25.0% |
| Buy | 3 | 75.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
- Fiscal year ending Oct 31, 2027
- -$0.31
- EPS consensus
- Next report
- Jan 11, 2027
- Estimated
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Oct 31, 2027 | -$0.31 | -$0.31 to -$0.31 | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Jan 31, 2027 | -$0.08 | -$0.08 to -$0.08 | 1 |
Estimate Revisions
No EPS estimate for the 2 periods below was revised in the last 30 days.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Oct 31, 2027 | 0 | 0 |
| Quarter ending Jan 31, 2027 | 0 | 0 |
EPS Trend
The EPS consensus for the fiscal year ending Oct 31, 2027 has held over the last 90 days.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Oct 31, 2027 | -$0.31 | -$0.31 | -$0.31 | -$0.31 | -$0.31 | N/A |
| Quarter ending Jan 31, 2027 | -$0.08 | -$0.08 | -$0.08 | -$0.08 | -$0.08 | N/A |
Frequently Asked Questions About ANIX
What is the ANIX stock forecast?
Consensus analyst estimates put Anixa Biosciences's EPS at -$0.31 for the fiscal year ending Oct 31, 2027. The consensus rating from 4 analysts is Buy.
How do analysts rate ANIX stock?
Of 4 analysts covering Anixa Biosciences, 1 rates it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ANIX next year?
For the fiscal year ending Oct 31, 2027, the consensus EPS estimate is -$0.31, with estimates from -$0.31 to -$0.31 from 1 analyst.
How many analysts cover ANIX?
4 analysts rate Anixa Biosciences stock, and 1 analyst estimates its EPS for the fiscal year ending Oct 31, 2027.
ANIX pages: Overview, Earnings, Forecast, Financials, Competitors